Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (1027) Zipsor (diclofenac potassium), Xanodyne,
...Newly Approved Drug Therapies (1027) Zipsor (diclofenac potassium), Xanodyne, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Zipsor (diclofenac potassium) Company: Xanodyne Approval Status: Approved June 2009 Treatment Area: mild to moderate acute pain General ...
View Page

2.  Newly Approved Drug Therapies (1030) Cambia (diclofenac potassium for oral solution), Kowa Pharmaceuticals,
...Newly Approved Drug Therapies (1030) Cambia (diclofenac potassium for oral solution), Kowa Pharmaceuticals, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Cambia (diclofenac potassium for oral solution) Company: Kowa Pharmaceuticals Approval Status: Approved June of 2009 Treatment Area: migraine ...
View Page

3.  Study Posting (3716) Trial #158772, Hypertension (High Blood Pressure), Waterbury, CT
...8-Week Forced-Titration Study of the Efficacy and Safety of Olmesartan Medoxomil versus Losartan Potassium in Hypertensive Subjects. This study is for men or women who are age 18 years ...
...8-Week Forced-Titration Study of the Efficacy and Safety of Olmesartan Medoxomil versus Losartan Potassium in Hypertensive Subjects. Hypertension (High Blood Pressure) Waterbury, CT 158772 Clinical Trial Participation If you ...
View Page

4.  Study Posting (2975) Trial #158369, Hypertension (High Blood Pressure), Dallas, TX
...study evaluates the investigational product, olmesartan medoxamil at 40 mg once daily, compared to losartan potassium 100 mg once daily. Everyone gets an active form of medication - there is no placebo ...
View Page

5.  Study Posting (5362) Trial #158456, Hypertension (High Blood Pressure), Boise, ID
...8-week Forced-titration Study of the Efficacy and Safety of Olmesartan Medoxomil Versus Losartan Potassium in Hypertensive Subjects Inclusion Criteria: • Males or females aged > 18 years who are not institutionalized ...
...may limit the ability to evaluate the efficacy or safety of olmesartan medoxomil and losartan potassium, including cardiovascular, renal (including the absence of one kidney), pulmonary, hepatic, gastrointestinal (including clinically significant ...
View Page

6.  Newly Approved Drug Therapies (578) Alamast, Santen,
...Name: Alamast Company: Santen Approval Status: Approved September 1999 Treatment Area: Ophthalmology General Information Pemirolast potassium ophthalmic solution. Mechanism of Action Eye drops. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 ...
View Page

7.  Newly Approved Drug Therapies (390) Timentin, SmithKline Beecham,
...Approval Status: Approved January 1998 Treatment Area: Infections in children General Information Timentin (disodium/clavulanate potassium) has been approved as an injectable antibiotic for use in treating a wide range of ...
View Page

8.  CenterWatch: Neurology Approved Drug Therapies
...Axona (caprylidene) ; Accera; For the treatment of Alzheimer's disease, Approved March 2009 Cambia (diclofenac potassium for oral solution) ; Kowa Pharmaceuticals; For the treatment of migraine attacks, Approved June of 2009 ...
...For the treatment of infantile spasms and complex partial seizures, Approved August 2009 Zipsor (diclofenac potassium) ; Xanodyne; For the treatment of mild to moderate acute pain, Approved June 2009 Drugs Approved ...
View Page

9.  Newly Approved Drug Therapies (1080) Ampyra (dalfampridine), Acorda,
...2010 Treatment Area: walking in patients with multiple sclerosis General Information Ampyra (dalfampridine) is a potassium channel blocker that enhances conduction in damaged nerves. The exact mechanism by which dalfampridine exerts ...
...sclerosis relapse • Paresthesia • Nasopharyngitis • Constipation • Dyspepsia • Pharyngolaryngeal pain Mechanism of Action Ampyra (dalfampridine) is a potassium channel blocker, available in a 10 mg tablet strength. Each tablet contains 10 mg dalfampridine ...
View Page

10.  Newly Approved Drug Therapies (365) Timentin, SmithKline Beecham,
...Status: Approved December 1997 Treatment Area: septicemia General Information Timentin, a Ticarcillin disodium and clavulante potassium injection, has been approved for use in children three months to 16 years of age ...
View Page

11.  Newly Approved Drug Therapies (60) Augmentin (amoxicillin/clavulanate), SmithKline Beecham,
...consists of a new tablet containing 875 mg of amoxicillin and 125 mg of clavulanate potassium. In addition, the currently marketed tablet containing 500 mg of amoxicillin and 125 mg of clavulanate potassium can now be prescribed on a twice-a-day regimen for less severe infections that ...
View Page

12.  Newly Approved Drug Therapies (894) Amitiza (lubiprostone), Sucampo/Takeda,
...to increase the production of chloride-rich intestinal fluid without significantly affecting serum sodium or potassium concentrations. Increased intestinal fluid production has been shown to promote gastrointestinal motility. Amitiza is specifically ...
View Page

13.  Study Posting (28) Trial #20046, Vascular Diseases, Atlanta, GA
...an FDA approved oral drug for high blood pressure (Trade name - Cozaar / generic name - losartan potassium) in treating patients with peripheral arterial disease due to atherosclerosis. The trial is seeking patients ...
View Page

14.  Study Posting (28) Trial #20050, Peripheral Vascular Disease, Atlanta, GA
...an FDA approved oral drug for high blood pressure (Trade name - Cozaar / generic name - losartan potassium) in treating patients with peripheral arterial disease due to atherosclerosis. The trial is seeking patients ...
View Page

15.  Study Posting (28) Trial #20049, Peripheral Arterial Occlusive Disease, Atlanta, GA
...an FDA approved oral drug for high blood pressure (Trade name - Cozaar / generic name - losartan potassium) in treating patients with peripheral arterial disease due to atherosclerosis. The trial is seeking patients ...
View Page

16.  Study Posting (28) Trial #20048, Limb Preservation and Amputation, Atlanta, GA
...an FDA approved oral drug for high blood pressure (Trade name - Cozaar / generic name - losartan potassium) in treating patients with peripheral arterial disease due to atherosclerosis. The trial is seeking patients ...
View Page

17.  Study Posting (28) Trial #20047, Circulation Disorders, Atlanta, GA
...an FDA approved oral drug for high blood pressure (Trade name - Cozaar / generic name - losartan potassium) in treating patients with peripheral arterial disease due to atherosclerosis. The trial is seeking patients ...
View Page

18.  Newly Approved Drug Therapies (654) Micardis HCT (telmisartan and hydrochlorothiazide), Boehringer Ingelheim,
...volume, with consequent increases in plasma renin activity, increases in aldosterone secretion, increases in urinary potassium loss, and decreases n serum potassium. The renin-aldosterone link is mediated by angiotensin II, so coadministration of an angiotensin II ...
View Page

19.  Study Posting (5234) Trial #158686, Hypertension (High Blood Pressure), Miami, FL
...a secondary form of hypertension • serum sodium less than the lower limit of normal serum potassium less than 3.5 or more than 5.5 at visit 1 • pregnant or nursing ...
View Page

20.  Newly Approved Drug Therapies (646) Atacand (candesartan cilexetil), AstraZeneca,
...volume, with consequent increases in plasma renin activity, increases in aldosterone secretion, increases in urinary potassium loss, and decreases in serum potassium. (from FDA Label) Additional Information Approximately one in every four American adults, and more than ...
View Page